IBDEI2AM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38899,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,38899,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,38900,0)
 ;;=L40.8^^151^1904^39
 ;;^UTILITY(U,$J,358.3,38900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38900,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,38900,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,38900,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,38901,0)
 ;;=L89.95^^151^1904^29
 ;;^UTILITY(U,$J,358.3,38901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38901,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Unstageable (Covered by Eschar)
 ;;^UTILITY(U,$J,358.3,38901,1,4,0)
 ;;=4^L89.95
 ;;^UTILITY(U,$J,358.3,38901,2)
 ;;=^5133660
 ;;^UTILITY(U,$J,358.3,38902,0)
 ;;=L89.92^^151^1904^25
 ;;^UTILITY(U,$J,358.3,38902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38902,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 2
 ;;^UTILITY(U,$J,358.3,38902,1,4,0)
 ;;=4^L89.92
 ;;^UTILITY(U,$J,358.3,38902,2)
 ;;=^5133667
 ;;^UTILITY(U,$J,358.3,38903,0)
 ;;=L89.93^^151^1904^26
 ;;^UTILITY(U,$J,358.3,38903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38903,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 3
 ;;^UTILITY(U,$J,358.3,38903,1,4,0)
 ;;=4^L89.93
 ;;^UTILITY(U,$J,358.3,38903,2)
 ;;=^5133668
 ;;^UTILITY(U,$J,358.3,38904,0)
 ;;=L89.94^^151^1904^27
 ;;^UTILITY(U,$J,358.3,38904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38904,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 4
 ;;^UTILITY(U,$J,358.3,38904,1,4,0)
 ;;=4^L89.94
 ;;^UTILITY(U,$J,358.3,38904,2)
 ;;=^5133669
 ;;^UTILITY(U,$J,358.3,38905,0)
 ;;=L89.90^^151^1904^28
 ;;^UTILITY(U,$J,358.3,38905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38905,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage Unspec
 ;;^UTILITY(U,$J,358.3,38905,1,4,0)
 ;;=4^L89.90
 ;;^UTILITY(U,$J,358.3,38905,2)
 ;;=^5133666
 ;;^UTILITY(U,$J,358.3,38906,0)
 ;;=L89.91^^151^1904^24
 ;;^UTILITY(U,$J,358.3,38906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38906,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 1
 ;;^UTILITY(U,$J,358.3,38906,1,4,0)
 ;;=4^L89.91
 ;;^UTILITY(U,$J,358.3,38906,2)
 ;;=^5133664
 ;;^UTILITY(U,$J,358.3,38907,0)
 ;;=L76.21^^151^1904^22
 ;;^UTILITY(U,$J,358.3,38907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38907,1,3,0)
 ;;=3^Postprocedure Hemor/Hemtom of Skin/SQ Tissue Following Derm Procedure
 ;;^UTILITY(U,$J,358.3,38907,1,4,0)
 ;;=4^L76.21
 ;;^UTILITY(U,$J,358.3,38907,2)
 ;;=^5009306
 ;;^UTILITY(U,$J,358.3,38908,0)
 ;;=L76.22^^151^1904^23
 ;;^UTILITY(U,$J,358.3,38908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38908,1,3,0)
 ;;=3^Postprocedure Hemor/Hemtom of Skin/SQ Tissue Following Oth Procedure
 ;;^UTILITY(U,$J,358.3,38908,1,4,0)
 ;;=4^L76.22
 ;;^UTILITY(U,$J,358.3,38908,2)
 ;;=^5009307
 ;;^UTILITY(U,$J,358.3,38909,0)
 ;;=L41.9^^151^1904^3
 ;;^UTILITY(U,$J,358.3,38909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38909,1,3,0)
 ;;=3^Parapsoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,38909,1,4,0)
 ;;=4^L41.9
 ;;^UTILITY(U,$J,358.3,38909,2)
 ;;=^5009177
 ;;^UTILITY(U,$J,358.3,38910,0)
 ;;=L70.5^^151^1904^13
 ;;^UTILITY(U,$J,358.3,38910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38910,1,3,0)
 ;;=3^Picker's Acne
 ;;^UTILITY(U,$J,358.3,38910,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,38910,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,38911,0)
 ;;=L81.9^^151^1904^14
 ;;^UTILITY(U,$J,358.3,38911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38911,1,3,0)
 ;;=3^Pigmentation Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,38911,1,4,0)
 ;;=4^L81.9
 ;;^UTILITY(U,$J,358.3,38911,2)
 ;;=^5009319
 ;;^UTILITY(U,$J,358.3,38912,0)
 ;;=L66.3^^151^1904^7
 ;;^UTILITY(U,$J,358.3,38912,1,0)
 ;;=^358.31IA^4^2
